Effectiveness and Safety of IV Thrombolysis Before Hospital Transfer for Thrombectomy in Patients With Basilar Artery Occlusion
Neurol 105:e214355, Liebart,S.,et al, 2025
Upbeat Nystagmus From Dorsolateral Pontine Hemorrhagic Transformation
Neurol 106:e214467, Chen,H. & Li, J., 2025
Necrotizing Granulomatous Encephalitis in a Patient After a Pericallosal Aneurysm Stent-Assisted Coil
Neurol 106:e214470, Kaneko,K.N.,et al, 2025
Chasing the New Dragon, Toxic Spongiform Leukoencephalopathy with Chronic Fentanyl Inhalation
Neurol 106:e214517, Maisenbacher,M. & Jayagopal, L.A., 2025
Large Language Models in Neurological Practice: Real-World Study
J Med Internet Res 27:e73212, Maiorana,N.V.,et al, 2025
Frequency, Risk Factors, and Outcomes of Strokes in Patients with Primary Glioma After Cranial Radiation
Neurol 105:e213902, Ryan,D.,et al, 2025
Risdiplam in Presymptomatic Spinal Muscular Atrophy
NEJM 393:671-682, Finkel,R.S.,et al, 2025
Clinicopathologic Conference, Lyme Carditis
NEJM 393:799-807, Case 24-2025, 2025
Educational Strategies for Clinical Supervision of Artificial Intelligence Use
NEJM 393:786-797, Abdulnour,R-E. E.,et al, 2025
Endovascular Treatment in Acute Ischemic Stroke Due to Occlusion of Medium or Distal Vessels
Neurol 105:e214015, Palaiodimou,L.,et al, 2025
Infantile Epileptic Spasms Syndrome (West Syndrome)
Stat Pearls PMID:30725936, Smith,M.S.,et al, 2025
Emergent Carotid Artery Stenting in Patients with Acute Ischemic Stroke with Tandem Lesions, One-Year Follow-Up Results from the SECURIS Study
Neurol 105:e214067, Ezcurra-Diaz,G.,et al, 2025
AI in Neurology: Everything, Everywhere, all at One PRT 2:Speech, Sentience, Scruples, and Service
Ann Neurol 98:431-447, Rizzo, M., 2025
The Role of GLP-1 (Glucagon-Like Peptide-1) Receptor Agonists in Primary Stroke Prevention
Stroke 56:e307-e309, Inikori,E.,et al, 2025
The Multifactorial Nature of Ischemic Stroke in Malignancy
Stroke 56:e303-e306, Doyle,C.L.,et al, 2025
Unmasking Cerebrotendinous Xanthomatosis, Clinical Recognition of a Treatable Cause of Progressive Ataxia
Neurol 105:e214099, Mizutani,H.,et al, 2025
Clinicopathologic Conference, Chagas Disease
NEJM 393:1216-1225, Case 27-2025, 2025
Atypical Diabetic Neuropathies
BMJ 390:e081109, McCray,B.A.,et al, 2025
Neuroimaging Findings in Children and Young Adults with Neurotoxicity after CAR T-Cell Therapy for B-Cell Malignancies
Neurol 105:e214086, McGuire,J.L.,et al, 2025
Idiopathic Intracranial Hypertension
NEJM 393:1409-1414, Horton,J.C., 2025
General AI May Revolutionize Neurology-Or It Might Be Bad
JAMA Neurol 82:977-978, Westover,M.B., & Westover A.M., 2025
Endovascular Thrombectomy Versus Best Medical Therapy for Large Vessel Occlusion Stroke Beyond 24 Hours: A Systematic Review and Meta-Analysis
Stroke 56:3127-3137, Rodriguez-Caliemnes,A.,et al, 2025
Effectiveness of Endovascular Treatment for Acute Mild Basilar Artery Occlusion Stroke:A Multicenter Real-World Study
Stroke 56:3187-3198, Xiao,Y.,et al, 2025
Acromegaly
NEJM 393:1926-1939, Giustina,A. & Colao,A.,, 2025
Clinicopathologic Conference, Subacute Painless Thyroiditis
NEJM 393:2036-2045, Quijije,N.V.,et al, 2025
Timing and Safety of Anticoagulation Reinitiation After Intracranial Hemorrhage in Patients with Mechanical Valves
Neurol 105:e214184, DAnna,L.,et al, 2025
Intravenous Thrombolysis Use Before Inter-Facility Transfer for Thrombectomy:Association with Efficacy and Safety Outcomes
Ann Neurol 98:871-880, Seners,P.,et al, 2025
FUTURE-AI: International Consensus Guideline for Trustworthy and Deployable Artificial Intelligence in Healthcare
BMJ 388:e081554, Lekadir,K.,et al, 2025
A 32 Year-Old Woman with Recurrent Intracerebral Hemorrhages
Neurol 104:e213422, Hindsholm,M.F.,et al, 2025
Clinicopathological Conference, Eosinophilic meningitis due to Angiostrongylus cantonensis infection
NEJM 392:699-709, Case 5-2025, 2025
Methamphetamine-Induced Basal Ganglia Toxicity Presenting as Parkinsonism
Neurol 104:e213365, Yi,M.Y.,et al, 2025
Commonly Used Interventional Procedures for Non-Cancer Chronic Spine Pain: A Clinical Practice Guideline
BMJ 388:e079970, Busse,J.W.,et al, 2025
Embolization of the Middle Meningeal Artery for Chronic Subdural Hematoma
NEJM 392:855-864, 918, Fiorella,D.,et al, 2025
Calcitonin Gene-Related Peptide-Targeted Therapy in Migraine: Current Role and Future Perspectives
Lancet 405:1014-1026, Versijpt,J.,et al, 2025
Severe Myotonic Crisis Resembling Malignant Hyperthermia
Neurol 104:e213497, Wadhwani,A.R.,et al, 2025
Inebilizumab for Treatment of IgG4-Related Disease
NEJM 392:1168-1177, Stone,J.H.,et al, 2025
Beyond Glucocorticoids for IgG4-Related Disease
NEJM 392:1232-1233, Spiera,R., 2025
Alteplase for Posterior Circulation Ischemic Stropke at 4.5 to 24 Hours
NEJM 392:1288-1296, Yan,S.,et al, 2025
Left Atrial Appendage Closure After Ablation for Atrial Fibrillation
NEJM 392:1277-1287, Wazni,O.M.,et al, 2025
Long-Term Effects of Antidarsagene Autotemcel for Metachromatic Leukodystrophy
NEJM 392:1609-1620, Fumagalli,F.,et al, 2025
Postprocedural Brachial Neuritis:Clinical, Electrodiagnostic, and Neuroimaging Features
AJNR 46:1050-1055, Ambati,V.S.,et al, 2025
Validation of an Artificial Intelligence-Powered Virtual Assistant for Emergency Triage in Neurology
Neurologist 30:155-163, Alessandro,L.,et al, 2025
Progress Toward Mitigating Disability Progression in Multiple Sclerosis
NEJM 392:1966-1968, Calabresi,P.A., 2025
General AI May Revolutionize Neurology 0 Or It Might be Bad
JAMA Neurol doi 10.1001/JAMANEUROL.2025.0905, Westover,M.B. & Westover,A.M., 2025
Upadacitinib - An Up-and-Comer for Treatment of Giant-Cell Arteritis
NEJM 392:2062-2064, Koster,M.J. & Warrington,K.J., 2025
Comprehensive Analysis of Neurologic Complications following Transradial Cerebral Angiography
AJNR 46:1166-1172, Kim,H.,et al, 2025
A 69-Year-Old Woman with Ophthalmoplegia
Neurol 104:e213763, Yu, H & Frey, J, 2025
Risk of Dementia in Individuals with Emergency Department Visits or Hospitalizations Due to Cannabis
JAMA Neurol 82:570-579, Myran,D.T.,et al, 2025
Aspirin Continuation or Discontinuation in Surgically Treated Chronic Subdural Hematoma, A Randomized Clinical Trial
JAMA Neurol 82:551-559, Kamenova,M.,et al, 2025
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
NEJM 392:2309-2320, Nowak,R.J.,et al, 2025